Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing cetylpyridinium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cetylpyridinium adverse reaction |
Causative agent (attribute) |
True |
Cetylpyridinium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to cetylpyridinium (finding) |
Causative agent (attribute) |
False |
Cetylpyridinium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cetylpyridinium chloride 0.066% lozenge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cetylpyridinium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cetylpyridinium chloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cetylpyridinium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cetylpyridinium chloride+ ascorbic acid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cetylpyridinium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cetylpyridinium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cetylpyridinium chloride (substance) |
Is a |
False |
Cetylpyridinium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely cetylpyridinium chloride 1 milligram/1 gram and lidocaine hydrochloride 3.3 milligram/1 gram conventional release dental gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cetylpyridinium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing cetylpyridinium and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing cetylpyridinium and guaifenesin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing cetylpyridinium and menthol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benzocaine- and cetylpyridinium-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cetylpyridinium-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing cetylpyridinium in oropharyngeal dosage form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cetylpyridinium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to cetylpyridinium (finding) |
Causative agent (attribute) |
True |
Cetylpyridinium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cetylpyridinium chloride (substance) |
Is modification of (attribute) |
True |
Cetylpyridinium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing ascorbic acid and cetylpyridinium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benzocaine- and cetylpyridinium-containing product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cetylpyridinium- and lidocaine-containing product in dental dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only cetylpyridinium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cetylpyridinium and lidocaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only benzocaine and cetylpyridinium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only cetylpyridinium and guaifenesin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ascorbic acid and cetylpyridinium only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cetylpyridinium and menthol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benzocaine and cetylpyridinium only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cetylpyridinium and lidocaine only product in dental dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cetylpyridinium only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cetylpyridinium only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing cetylpyridinium in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benzydamine and cetylpyridinium only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benzydamine and cetylpyridinium only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing benzydamine and cetylpyridinium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing benzydamine and cetylpyridinium in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing cetylpyridinium and chlorocresol and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Cetylpyridinium and chlorocresol and lidocaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing cetylpyridinium and chlorocresol and lidocaine in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Cetylpyridinium and chlorocresol and lidocaine only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetylpyridinium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |